Stereotaxis, Inc. (OTC:STXS)

Tuesday, May 5, 2020 | Web News
STEREOTAXIS INC (NYSE:STXS) ($3.49; $249.2M market cap), a company that designs, manufactures, and markets robotic systems and...
Friday, May 24, 2019 | Spotlight
STEREOTAXIS INC (OOTC:STXS) ($2.41; $142.9M market cap), a company that designs, manufactures, and markets robotic systems and...
Monday, May 13, 2019 | Spotlight
In our April 24, 2019 email, we mentioned that we had a chance to interview $STXS management and that our main takeaway was that the company is...
See All Research...
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Last updated October 24, 2018